Health
New HIV drug could cost just $40 a year, researchers say
A recent analysis has indicated that the HIV drug Lenacapavir, developed by Gilead Sciences, could be produced for as little as $26 to $40 per person annually. This finding contrasts sharply with its current cost of over $40,000 per person per year. The drug has shown remarkable efficacy, being